Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Bentancor, Leticia V ^a   Bilen, Marcos F ^b   Mejías, María P ^a   Fernández Brando, Romina J ^a   Panek, Cecilia A ^a   Ramos, Maria V ^a   Fernández, Gabriela C ^a   Isturiz, Martín ^a   Ghiringhelli, Pablo D ^b   Palermo, Marina S ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; DNA SEQUENCE; EMBRYO; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI INFECTION; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; TOXIN ANALYSIS; TOXIN SYNTHESIS; VERO CELL;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; PROMOTER REGIONS, GENETIC; SEQUENCE HOMOLOGY, NUCLEIC ACID; SHIGA TOXIN; VERO CELLS;

EID: 84874333460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057128     Document Type: Article

References (48)

1. Griffin PM, Tauxe RV, (1991) The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13: 60-98.
2. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, et al. (1997) Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 126: 505-513.
3. Caprioli A, Morabito S, Brugere H, Oswald E, (2005) Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 36: 289-311.
4. Lopez EL, Prado-Jimenez V, O'Ryan-Gallardo M, Contrini MM, (2000) Shigella and Shiga toxin-producing Escherichia coli causing bloody diarrhea in Latin America. Infect Dis Clin North Am 14: 41-65.
5. Rivas M, Miliwebsky E, Chinen I, Deza N, Leotta GA, (2006) The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina 66: 27-32.
6. Thompson GS, Shimizu H, Homans SW, Donohue-Rolfe A, (2000) Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements. Biochemistry 39: 13153-13156.
7. Neely MN, Friedman DI, (1998) Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 28: 1255-1267.
8. Little JW (1995) The SOS regulatory system, p. 453-479. In Linn ECC, Lynch AS, editors. Regulation of gene expression in Escherichia coli. Georgetown, TX: R.G. Landis.
9. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, et al. (2000) Quinolone antibiotics induce Shiga toxin encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181: 664-670.
10. Teel LD, Melton-Celsa AR, Schmitt CK, O'Brien AD, (2000) One of two copies of the gene for the activatable Shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage. Infect Immun 70: 4282-4291.
11. Acheson DW, Reidl J, Zhang X, Keusch GT, Mekalanos JJ, et al. (1998) In Vivo Transduction with Shiga Toxin 1-Encoding Phage. Infect Immun 66: 4496-4498.
12. Cornick NA, Helgerson AF, Mai V, Ritchie JM, Acheson DWK, (2006) In Vivo Transduction of an Stx-Encoding Phage in Ruminants. Appl Environ Microbiol 72: 5086-5088.
13. Schmidt H, (2001) Shiga-toxin-converting bacteriophages. Res Microbiol 152: 687-695.
14. Gamage SD, Strasser JE, Chalk CL, Weiss AA, (2003) Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun 71: 3107-3115.
15. Merril CR, Geier MR, Petricciani JC, (1971) Bacterial virus gene expression in human cells. Nature 233: 398-400.
16. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, et al. (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276 (28): 26204-10.
17. Zanghi CN, Sapinoro R, Bradel-Tretheway B, Dewhurst S, (2007) A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery. Nucleic Acids Res 35(8): e59.
18. Clark JR, March JB, (2004) Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol Med Microbiol 40: 21-26.
19. Lankes HA, Zanghi CN, Santos K, Capella C, Duke CM, et al. (2007) In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol 102: 1337-1349.
20. Sapinoro R, Rodrigo S, Schlesinger J, Dewhurst S, (2007) Fc receptor mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells. Virology 373: 274-286.
21. Shimada O, Ishikawa H, Tosaka-Shimada H, Atsumi S, (1999) Exocytotic secretion of toxins from macrophages infected with Escherichia coli O157. Cell Struct Funct 24: 247-253.
22. Poirier K, Faucher SP, Béland M, Brousseau R, Gannon V, et al. (2008) Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect Immun 76: 4814-4822.
23. Bentancor LV, Bilen M, Brando RJ, Ramos MV, Ferreira LC, et al. (2009) A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model. Clin Vaccine Immunol 16: 712-718.
24. George AA, Sharma M, Singh BN, Sahoo NC, Rao KV, (2006) Transcription regulation from a TATA and INR-less promoter: spatial segregation of promoter function. EMBO J 25: 811-821.
25. Takenouchi H, Kiyokawa N, Taguchi T, Matsui J, Katagiri YU, et al. (2004) Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells. J Cell Sci 117: 3911-3922.
26. Ptashne M (1992) A genetic switch: phage l and higher organisms. Cambridge, MA: Cell Press.
27. Ptashne M (2004) A genetic switch: phage lambda revisited, 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
28. Canchaya C, Proux C, Fournous G, Bruttin A, Brüssow H, (2003) Prophage genomics. Microbiol Mol Biol Rev 67: 238-276.
29. Gottesman S, Gottesman M, (1975) Excision of prophage λ in a cell-free system. Proc Natl Acad Sci USA 72: 2188-2192.
30. Wagner PL, Acheson DWK, Waldor MK, (2001) Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun 69: 1934-1937.
31. Darji A, Guzmán CA, Gerstel B, Wachholz P, Timmis KN, et al. (1997) Oral Somatic Transgene Vaccination Using Attenuated S. typhimurium. Cell 91: 765-775.
32. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP, (1998) Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92: 3172-3176.
33. Gahan ME, Webster DE, Wesselingh SL, Strugnell RA, Yang J, (2009) Bacterial Antigen Expression Is an Important Component in Inducing an Immune Response to Orally Administered Salmonella-Delivered DNA Vaccines Plos One. 4(6): e6062.
34. Geier MR, Merril CR, (1972) Lambda phage transcription in human fibroblasts. Virology 47: 638-643.
35. Baumann M, Pontiller J, Ernst W, (2010) Structure and basal transcription complex of RNA polymerase II core promoters in the mammalian genome: an overview. Mol Biotechnol 45: 241-247.
36. Orphanides G, Reinberg D, (2002) A unified theory of gene expression. Cell 108: 439-451.
37. Smale ST, Kadonaga JT, (2003) The RNA polymerase II core promoter. Annu Rev Biochem 72: 449-79.
38. Juven-Gershon T, Hsu JY, Theisen JW, Kadonaga JT, (2008) The RNA polymerase II core promoter- the gateway to transcription. Curr Opin Cell Biol 20: 253-259.
39. Juven-Gershon T, Kadonaga JT, (2010) Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev Biol 339: 225-229.
40. Lee TI, Young RA, (2000) Transcription of eukaryotic protein-coding genes. Annu Rev Genet 34: 77-137.
41. O'Loughlin EV, Robins-Browne RM, (2001) Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3: 493-507.
42. Obrig TG, Moran TP, Brown JE, (1987) The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. J Biochem 244: 287-294.
43. Endo Y, Tsurugi K, Yutsudo T, Takeda, Ogasawara T, et al. (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 45-50.
44. Nakagawa I, Nakata M, Kawabata S, Hamada S, (1999) Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells. Mol Microbiol 33: 1190-1199.
45. Shimada O, Ishikawa H, Tosaka-Shimada, Atsumi S, (1999) Rearrangements of actin cytoskeleton during infection with Escherichia coli O157 in macrophages. Cell Struct Funct 24: 237-246.
46. Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, et al. (2012) The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 122(2): 759-76.
47. Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, et al. (2002) Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun 70: 612-619.
48. Karmali MA, Petric M, Lim C, Cheung R, Arbus GS, (1985) Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol 22: 614-619.